CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Anti-Microbial Savior BioteQ Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Anti-Microbial Savior BioteQ Co Ltd
7F-2
No. 6, Siwei 3rd Road, Lingya District
Phone: +886 72237578p:+886 72237578 KAOHSIUNG, 802  Taiwan Ticker: 68646864
Business Summary
Anti Microbial Savior BioteQ Co Ltd is a Taiwan-based company mainly engaged in drug research and development. The Company’s main products include MEDIACE (new medical dressing), which absorbs wound exudate to maintain the wound in a moist environment, promotes wound healing, and releases antibacterial ingredients to prevent wound infection; FORMOSA-1117 (antibacterial drug), which has antibacterial effects on Gram-positive bacteria and multi-drug resistant bacteria; YUAN-03 (antiviral drug) , which has antiviral effects against human coronavirus hCoV-OC43 and SARS-CoV-2.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager GeorgeTsai 11/27/2018 4/2/2018
Head of Finance LiyuXu 2/18/2019 2/18/2019
Director MeilingLiao 3/28/2022 3/28/2022
4 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 28,000,000 (As of 3/20/2024)
Stock Exchange: TPO
Fax Number: +886 72233622


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024